Ministry of Commerce and Industry Inviting Comments on imposing anti dumping duty on imports of jute products from Bangladesh and Nepal
This is for your kind intimation that the Government has found sufficient prima facie evidence of dumping of the “Jute Products” , originating in or exported from Bangladesh and Nepal , injury to the domestic industry and a casual link between the alleged dumping and injury exist to justify initiation of an anti dumping investigations.
The designated authority (Directorate General of Anti Dumping & Allied Duties) therefore hereby initiates investigation into the alleged dumping and consequent injury to the domestic industry in terms of Rule 5 of the Rules to determine the existence , degree and effect of the alleged dumping and to recommend the amount of anti dumping duty, which if levied would be adequate to remove the ‘injury’ to the domestic industry.
In this regard, Ministry of Commerce and Industry has invited the stakeholders of the concerned industry to submit the information relevant to the investigations in the following prescribed manner:
In order to make any submission (including Appendices/Annexure attached thereto) are required to file the same in two separate sets :
a. One set marked as Confidential (with title, number of pages, index etc.)
b. the other set marked as Non –confidential (with title, number of pages, index, etc.)
The “Confidential “ or “non-confidential” submission must be clearly marked as “confidential “ or “non-confidential” at the top of each page.
For information claimed as confidential , the supplier of the information is required to provide a good cause statement along with the supplied information as to why such information can not be disclosed.
Ministry of Commerce and Industry initiation notification pertaining to anti-dumping investigation concerning imports of “Jute Product” originating in or exported from Bangladesh and Nepal is attached herewith for your kind consideration.
India comfortably goes through to the finals of the 8th Junior Men’s Asia Cup
Kuantan, Malaysia, 21st November 2015: Indian Junior Men’s Hockey team booked a berth in the final of the 8th Junior Men’s Asia Cup with a 6-1 win over Japan in the semi –finals. The match marked India’s second win over Japan in the tournament.
India started the first half with their usual flair and attacking play and within the first 12 minutes India opened their account through a field goal from Mandeep Singh.
Manpreet (jr.) added another goal to India’s tally in the next minute to take India 2-0 up in the semi -final. India didn’t look back after this and continued with their goal fest as Harmanpreet scored his 10th goal of the tournament from a penalty corner giving India a comfortable 3-0 lead. Vikramjit Singh’s field goal in the 27th minute consolidated India’s lead in the game. The first half ended with the score at 4-0 in India’s favour.
Japan started the second half with an attacking intent and was rewarded with a penalty corner which was converted by Yamada Shota giving Japan a much needed breather. However India struck back fiercely in the 48th minute through a penalty corner conversion by Harmanpreet Singh taking his tally to 11 goals in the tournament. The margin of the win was extended even further with Varun Kumar scoring from a penalty corner to make it 6-1 in India’s favour and booking a berth for India in the finals.
“The boys played really well making it a great day for us in the tournament. We are one step away from winning the tournament and it is the time when we all need to keep our calm. The team is well drilled and hungry for more. We will take the next match as any other normal game and focus on putting up a good tight show” said Harendra Singh, Coach, Indian Junior Men’s Hockey Team
India will play the winner of the semi –final between Pakistan and Korea tomorrow at Wisma Belia Hockey Stadium in Kuantan, Malaysia.
HOCKEY INDIA TEAM PARTNERS
‘Leveraging International Cooperation to boost Indian Innovation Ecosystem’
Dec 7th – 8th 2015: Vigyan Bhawan, New Delhi
Greetings from FICCI!
Federation of Indian Chambers of Commerce and Industry (FICCI) in collaboration with Department of Science & Technology, Government of India is organising its annual flagship event ‘Global R&D Summit 2015’ – a two day integrated conference and exhibition to be held from December 7-8, 2015, at Vigyan Bhawan, New Delhi. The theme of the conference is – ‘Leveraging International Cooperation to boost Indian Innovation Ecosystem’. Dr. Harsh Vardhan,Hon’ble Union Minister for Science & Technology & Earth Sciences, Govt. of India is scheduled to inaugurate the Global R & D Summit 2015 & Expo.
Last year, the Summit witnessed coming together of more than 70 subject- and domain- specific speakers from India and abroad who were engaged across 8 high-powered panel discussions and thematic sessions organized over the two days of the Summit. The audience turnout for the Summit was more than 400. Some of the countries which were represented in this summit included USA, France, UK, Japan, France, Sweden, Trinidad & Tobago, Germany, and South Korea. The Summit is attended in equal measures by representatives from the Government, Industry, and the Academia.
Concurrent to the conference, the summit will also host an exposition to showcase some of the major achievements and capabilities of leading R&D-focused organizations from industry, government and academia. It will offer tremendous opportunities for exhibitors to display some of their cutting-edge Innovations, Technologies, products and solutions to key customers, decision makers, business buyers, investors, scientific community and the media at large.The event aims to be a magnanimous milieu of policy-makers, startup leaders, innovators, investors, entrepreneurs, academia, industry, and international agencies. It will also render a high level networking opportunities with various actors from across the globe to Create, Connect and Collaborate to make the Indian Innovation Ecosystem the best in the World. Click on the hyperlink to download brochure and sponsorship dossier.
Considering the strategic role of your esteemed organisation in the R&D and innovation ecosystem of the country and its growing dominance in frontier areas of cutting-edge technology development, it is our immense pleasure to invite you to participate or nominate some of your colleagues and members of the organization to participate as “Delegates” for the conference.
Kindly send the duly filled in Registration form (click here to download). Payment options are also mentioned in the same. You can also log in to our websitehttp://www.ficcirndsummit.com/ and make the payment online. Please note that only RTGS/NEFT/DD will be accepted after 30th November 2015. NO CHEQUES WILL BE ACCEPTED AFTER THIS DATE.ONLY CASH PAYMENT WILL BE ACCEPTED AT THE ON-THE SPOT REGISTRATION DESK ON THE EVENT DAY.
Please refer to the E-flyer below:
for Best Quality in Service Delivery in Healthcare
New Delhi, November 30, 2015: Malabar Institute of Medical Sciences Ltd. (MIMS) has received the Healthcare Leadership Award from ABP News for the Best Quality in Service Delivery in Healthcare. An independent panel of judges comprising of Mandy Saven, Head of Food, Hospitality Stylus, Saket V. Rao, Vice President, Housing.com, Lene Tourn, Partner, Uncomuns, Nitin Bahl, Country Marketing Manager, Motorola Solutions India Pvt. Ltd, Ralph Brunner, CMO, MetLife, Suhasini Kirloskar, Chief of Marketing, GS Lab, Siddhartha Choudhary, Global Marketing Head, Water health International and Ben Foo, Marketing Director at McDonald’s Corporation Malaysia assessed healthcare providers that made the highest impact across performance and quality metrics and presented awards across 60 categories. Malabar Institute of Medical Sciences was recognized for their processes and quality improvements to ensure the best patient outcomes.
Dr. Rahul Menon, Chief Executive Officer of Malabar Institute of Medical Sciences said, ‘’This award is a validation of our efforts to ensure the highest quality standards to deliver safe, effective and compassionate care to our patients. Over the years we have focused on bringing the latest in medical advancements to improve health outcomes at affordable costs.’’